Skip to main content
Top
Published in: Virology Journal 1/2021

Open Access 01-12-2021 | Short report

Generation and immunogenicity analysis of recombinant classical swine fever virus glycoprotein E2 and Erns expressed in baculovirus expression system

Authors: Qiang Wei, Yilin Bai, Yapeng Song, Yunchao Liu, Wei Yu, Yaning Sun, Li Wang, Ruiguang Deng, Guangxu Xing, Gaiping Zhang

Published in: Virology Journal | Issue 1/2021

Login to get access

Abstract

Classical swine fever (CSF) caused by the classical swine fever virus (CSFV) is a highly contagious swine disease resulting in large economical losses worldwide. The viral envelope glycoprotein E2 and Erns are major targets for eliciting antibodies against CSFV in infected animals. In this report, the glycoprotein E2 and Erns were expressed using the baculovirus system and their protective immunity in rabbits were tested. Twenty CSFV seronegative rabbits were randomly divided into five groups. Each rabbit was intramuscularly immunized with CSFV-E2, CSFV-Erns, or their combination (CSFV-E2 + Erns). Besides, a commercial CSFV vaccine (C-strain) and PBS were used as positive or negative controls, respectively. Four weeks after the second immunization, all the rabbits were challenged with 100 RID50 of CSFV C-strain. High levels of CSFV E2-specific antibody, neutralizing antibody and cellular immune responses to CSFV were elicited in the rabbits inoculated with C-strain, CSFV-E2, and CSFV-E2 + Erns. And the rabbits inoculated with the three vaccines received complete protection against CSFV C-strain. However, no neutralizing antibody was detected in the Erns vaccinated rabbits and the rabbits exhibited fever typical of CSFV, suggesting the Erns alone is not able to induce a protective immune response. Taken together, while the Erns could not confer protection against CSFV, E2 and E2 + Erns could not only elicit humoral and cell-mediated immune responses but also confer complete protection against CSFV C-strain in rabbits.
Literature
1.
go back to reference Moennig V, Floegel-Niesmann G, Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J. 2003;165(1):11–20.CrossRef Moennig V, Floegel-Niesmann G, Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J. 2003;165(1):11–20.CrossRef
2.
go back to reference Meyers G, Thiel HJ, Rumenapf T. Classical swine fever virus: recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles. J Virol. 1996;70(3):1588–95.CrossRef Meyers G, Thiel HJ, Rumenapf T. Classical swine fever virus: recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles. J Virol. 1996;70(3):1588–95.CrossRef
3.
go back to reference Thiel HJ, Stark R, Weiland E, et al. Hog cholera virus: molecular composition of virions from a pestivirus. J Virol. 1991;65(9):4705–12.CrossRef Thiel HJ, Stark R, Weiland E, et al. Hog cholera virus: molecular composition of virions from a pestivirus. J Virol. 1991;65(9):4705–12.CrossRef
4.
go back to reference Schneider R, Unger G, Stark R, et al. Identification of a structural glycoprotein of an RNA virus as a ribonuclease. Science. 1993;261(5125):1169–71.CrossRef Schneider R, Unger G, Stark R, et al. Identification of a structural glycoprotein of an RNA virus as a ribonuclease. Science. 1993;261(5125):1169–71.CrossRef
5.
go back to reference Branza-Nichita N, Lazar C, Dwek RA, et al. Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns). Biochem Biophys Res Commun. 2004;319(2):655–62.CrossRef Branza-Nichita N, Lazar C, Dwek RA, et al. Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns). Biochem Biophys Res Commun. 2004;319(2):655–62.CrossRef
6.
go back to reference Sainz IF, Holinka LG, Lu Z, et al. Removal of a N-linked glycosylation site of classical swine fever virus strain Brescia Erns glycoprotein affects virulence in swine. Virology. 2008;370(1):122–9.CrossRef Sainz IF, Holinka LG, Lu Z, et al. Removal of a N-linked glycosylation site of classical swine fever virus strain Brescia Erns glycoprotein affects virulence in swine. Virology. 2008;370(1):122–9.CrossRef
7.
go back to reference Gavrilov BK, Rogers K, Fernandez-Sainz IJ, et al. Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins. Virology. 2011;420(2):135–45.CrossRef Gavrilov BK, Rogers K, Fernandez-Sainz IJ, et al. Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins. Virology. 2011;420(2):135–45.CrossRef
8.
go back to reference Gr R, Mv B, Gf K, et al. The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. J Virol. 2005;79(6):3787–96.CrossRef Gr R, Mv B, Gf K, et al. The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. J Virol. 2005;79(6):3787–96.CrossRef
9.
go back to reference Hg VG, Ac V, Mm H, et al. Determinants of virulence of classical swine fever virus strain Brescia. J Virol. 2004;78(16):8812–23.CrossRef Hg VG, Ac V, Mm H, et al. Determinants of virulence of classical swine fever virus strain Brescia. J Virol. 2004;78(16):8812–23.CrossRef
10.
go back to reference Weiland E, Ahl R, Stark R, et al. A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J Virol. 1992;66(6):3677–82.CrossRef Weiland E, Ahl R, Stark R, et al. A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J Virol. 1992;66(6):3677–82.CrossRef
11.
go back to reference Konig M, Lengsfeld T, Pauly T, et al. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol. 1995;69(10):6479–86.CrossRef Konig M, Lengsfeld T, Pauly T, et al. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol. 1995;69(10):6479–86.CrossRef
12.
go back to reference Bouma A, De Smit AJ, De Jong MC, et al. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine. 2000;18(14):1374–81.CrossRef Bouma A, De Smit AJ, De Jong MC, et al. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine. 2000;18(14):1374–81.CrossRef
13.
go back to reference Madera R, Gong W, Wang L, et al. Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge. BMC Vet Res. 2016;12(1):197.CrossRef Madera R, Gong W, Wang L, et al. Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge. BMC Vet Res. 2016;12(1):197.CrossRef
14.
go back to reference Lin GJ, Liu TY, Tseng YY, et al. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response. Vet Microbiol. 2009;139(3–4):369–74.CrossRef Lin GJ, Liu TY, Tseng YY, et al. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response. Vet Microbiol. 2009;139(3–4):369–74.CrossRef
15.
go back to reference Blome S, Moss C, Reimann I, et al. Classical swine fever vaccines-state-of-the-art. Vet Microbiol. 2017;206:10–20.CrossRef Blome S, Moss C, Reimann I, et al. Classical swine fever vaccines-state-of-the-art. Vet Microbiol. 2017;206:10–20.CrossRef
16.
go back to reference Zhang H, Li X, Peng G, et al. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits. Vaccine. 2014;32(49):6607–13.CrossRef Zhang H, Li X, Peng G, et al. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits. Vaccine. 2014;32(49):6607–13.CrossRef
17.
go back to reference Tong W, Zheng H, Li GX, et al. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV. Antiviral Res. 2020;173:104652.CrossRef Tong W, Zheng H, Li GX, et al. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV. Antiviral Res. 2020;173:104652.CrossRef
18.
go back to reference Lin GJ, Deng MC, Chen ZW, et al. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission. Vaccine. 2012;30(13):2336–41.CrossRef Lin GJ, Deng MC, Chen ZW, et al. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission. Vaccine. 2012;30(13):2336–41.CrossRef
19.
go back to reference Blome S, Meindl-Bohmer A, Loeffen W, et al. Assessment of classical swine fever diagnostics and vaccine performance. Rev Sci Tech. 2006;25(3):1025–38.CrossRef Blome S, Meindl-Bohmer A, Loeffen W, et al. Assessment of classical swine fever diagnostics and vaccine performance. Rev Sci Tech. 2006;25(3):1025–38.CrossRef
20.
go back to reference Dong XN, Chen YH. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine. 2007;25(2):205–30.CrossRef Dong XN, Chen YH. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine. 2007;25(2):205–30.CrossRef
21.
go back to reference Ganges L, Crooke HR, Bohorquez JA, et al. Classical swine fever virus: the past, present and future. Virus Res. 2020;289:198151.CrossRef Ganges L, Crooke HR, Bohorquez JA, et al. Classical swine fever virus: the past, present and future. Virus Res. 2020;289:198151.CrossRef
22.
go back to reference Lin M, McRae H, Dan H, et al. High-resolution epitope mapping for monoclonal antibodies to the structural protein Erns of classical swine fever virus using peptide array and random peptide phage display approaches. J Gen Virol. 2010;91:2928–40.CrossRef Lin M, McRae H, Dan H, et al. High-resolution epitope mapping for monoclonal antibodies to the structural protein Erns of classical swine fever virus using peptide array and random peptide phage display approaches. J Gen Virol. 2010;91:2928–40.CrossRef
23.
go back to reference Lin M, Trottier E, Pasick J, et al. Identification of antigenic regions of the Erns protein for pig antibodies elicited during classical swine fever virus infection. J Biochem. 2004;136(6):795–804.CrossRef Lin M, Trottier E, Pasick J, et al. Identification of antigenic regions of the Erns protein for pig antibodies elicited during classical swine fever virus infection. J Biochem. 2004;136(6):795–804.CrossRef
24.
go back to reference Meyer D, Aebischer A, Muller M, et al. New insights into the antigenic structure of the glycoprotein E(rns) of classical swine fever virus by epitope mapping. Virology. 2012;433(1):45–54.CrossRef Meyer D, Aebischer A, Muller M, et al. New insights into the antigenic structure of the glycoprotein E(rns) of classical swine fever virus by epitope mapping. Virology. 2012;433(1):45–54.CrossRef
25.
go back to reference Fetzer C, Tews BA, Meyers G. The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor. J Virol. 2005;79(18):11901–13.CrossRef Fetzer C, Tews BA, Meyers G. The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor. J Virol. 2005;79(18):11901–13.CrossRef
26.
go back to reference Tews BA, Meyers G. The pestivirus glycoprotein Erns is anchored in plane in the membrane via an amphipathic helix. J Biol Chem. 2007;282(45):32730.CrossRef Tews BA, Meyers G. The pestivirus glycoprotein Erns is anchored in plane in the membrane via an amphipathic helix. J Biol Chem. 2007;282(45):32730.CrossRef
27.
go back to reference Aberle D, Muhle-Goll C, Bürck J, et al. Structure of the membrane anchor of pestivirus glycoprotein Erns, a long tilted amphipathic helix. PLoS Pathog. 2014;10(2):e1003973.CrossRef Aberle D, Muhle-Goll C, Bürck J, et al. Structure of the membrane anchor of pestivirus glycoprotein Erns, a long tilted amphipathic helix. PLoS Pathog. 2014;10(2):e1003973.CrossRef
28.
go back to reference Wang HG, Ning YB, Ying C, et al. Development and application of a RT-nestPCR assay for differential detection of C-strain and wild-type viruses of classical swine fever virus. Sustain Agric Res. 2013;2(3):27–40. Wang HG, Ning YB, Ying C, et al. Development and application of a RT-nestPCR assay for differential detection of C-strain and wild-type viruses of classical swine fever virus. Sustain Agric Res. 2013;2(3):27–40.
29.
go back to reference Li Y, Wang J, Kanai R, et al. Crystal structure of glycoprotein E2 from bovine viral diarrhea virus. Proc Natl Acad Sci USA. 2013;110(17):6805–10.CrossRef Li Y, Wang J, Kanai R, et al. Crystal structure of glycoprotein E2 from bovine viral diarrhea virus. Proc Natl Acad Sci USA. 2013;110(17):6805–10.CrossRef
Metadata
Title
Generation and immunogenicity analysis of recombinant classical swine fever virus glycoprotein E2 and Erns expressed in baculovirus expression system
Authors
Qiang Wei
Yilin Bai
Yapeng Song
Yunchao Liu
Wei Yu
Yaning Sun
Li Wang
Ruiguang Deng
Guangxu Xing
Gaiping Zhang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2021
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-021-01507-1

Other articles of this Issue 1/2021

Virology Journal 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.